1. At a Glance – The Plastic Surgeon of Pharma Devices Is Minting Margins
₹9,446 crore market cap. ₹2,055 stock price. 66.4 P/E. 26.6% OPM. 96.5% quarterly profit growth.
And yet the stock is down 20.8% in the last 3 months.
Ladies and gentlemen, welcome to the paradox of Shaily Engineering Plastics Ltd — a precision injection-moulding specialist quietly riding the GLP-1 injection wave while the market debates whether it deserves a superstar valuation.
December 2025 quarter delivered ₹236 crore in sales and ₹35.6 crore PAT. That’s a 26.9% revenue growth and a dramatic 96.5% jump in profit YoY. OPM touched 27%. ROCE stands at 17%. ROE at 15.3%.
But here’s the spicy bit — the stock trades at 16.7 times book value.
So the big question:
Is this a future medical-device powerhouse in the making… or is the market already pricing in a flawless future?
Grab your plastic syringe. We are going deep.
2. Introduction – From Toys to GLP-1 Pens, This Escalated Quickly
Once upon a time, Shaily was making plastic components for consumer goods. FMCG packaging. Home furnishings. Toys.
Then pharma devices entered the chat.
And suddenly, this wasn’t just a plastic moulder — this became a pen-injector capacity expansion story.
Today:
- 78.6% revenue from exports
- 17.1% revenue from healthcare
- Signed 6 contracts for GLP-1 and other therapy pen injectors
- Planning ₹100 crore capex in FY26
- Sequential capacity jump from ~45 million to ~85 million pen devices
That’s not small ambition.
They’re even building two 80-parts-per-minute lines targeting 50–60 million extra units by December 2026.
Let me ask you something:
When a company moves from LED housings to medical injectors…
Do margins change?
Do valuations change?
Do risks change?
Exactly.
Let’s decode.
3. Business Model – WTF Do They Even Do?
Shaily is a precision plastic injection moulding specialist.
Translation:
They don’t sell branded products. They manufacture complex plastic components and sub-assemblies for OEMs.
Three segments:
1️ Consumer (74.3% of 9MFY25 revenue)
- Home furnishing components
- FMCG packaging
- LED light parts
- Toys (via partnership with Spin Master)
- Two global retail chains onboarding from FY26
This is bread-and-butter revenue. Stable. Export-heavy.
2️ Healthcare (17.1%)
This is where the future is hiding.
Products:
- Pen Injectors
- Auto-injectors
- Wearable injectors
- Pharma packaging
- Platform devices
GLP-1 therapy pens are the hot global trend.
If weight-loss drugs are the “Netflix
